Nemes Rush Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253 | Sell |
2
-6,379
| -100% | -$807K | ﹤0.01% | 699 |
|
|
2025
Q1 | $816K | Sell |
6,381
-49
| -0.8% | -$6.27K | 0.1% | 97 |
|
|
2024
Q4 | $850K | Buy |
6,430
+6,019
| +1,464% | +$796K | 0.11% | 98 |
|
|
2024
Q3 | $56.4K | Buy |
+411
| New | +$56.4K | 0.01% | 249 |
|
|
2024
Q2 | – | Sell |
-411
| Closed | -$56.4K | – | 639 |
|
|
2024
Q1 | $56.4K | Sell |
411
-1,956
| -83% | -$268K | 0.01% | 257 |
|
|
2023
Q4 | $322K | Buy |
+2,367
| New | +$322K | 0.05% | 135 |
|